DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
A randomized phase III, double-blind, placebo-controlled, multi-center study to evaluate the efficacy and safety of everolimus (RAD001) in adult patients with advanced hepatocellular carcinoma after failure of sorafenib treatment–The EVOLVE-1 Study.
Available at:
http://clinicaltrials.gov/ct2/show/NCT01035229 . Accessed January 11, 2012
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.